Home Innate Pharma

Innate Pharma

In operation
Post-IPO Round
Biopharmaceutical Manufacturer
Basic
Enterprise Profile

Basic Information

Innate Pharma is a global biotechnology company at the clinical stage, focusing on oncology. It is dedicated to improving patient treatment and clinical outcomes by leveraging therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma's extensive antibody pipeline includes several potential first-in-class clinical and preclinical candidates for treating cancers with significant unmet medical needs. Innate is a pioneer in understanding natural killer cell (NK cell) biology and has expanded its expertise in tumor microenvironments, tumor antigens, and antibody engineering.
Innate Pharma S.A.
Marseille,Provence-Alpes-Côted'Azur,France
51~100 people
January 01, 1999
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products Immune Cell Therapy
Technology
Targeted Technology Immunological Techniques
Concept
Immune System Diseases Therapeutic Products Lung Cancer Lymphoma
Application Scenarios
Innovative Drugs Monoclonal Antibody